Fractyl Health, Inc. Investment Income, Interest
Fractyl Health, Inc. (GUTS) reported Investment Income, Interest of $431.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-10
- Fractyl Health, Inc. investment income, interest for the quarter ending 2026-06-30 was $431.00K, a 90.71% increase year-over-year.
- Fractyl Health, Inc. investment income, interest for the quarter ending 2026-03-31 was $593.00K, a 17.89% increase year-over-year.
- Fractyl Health, Inc. investment income, interest for the quarter ending 2025-12-31 was $645.00K, a 11.16% decline year-over-year.
- Fractyl Health, Inc. investment income, interest for the quarter ending 2025-09-30 was $166.00K, a 82.47% decline year-over-year.
- Fractyl Health, Inc. investment income, interest for fiscal 2025 was $1.54M, a 62.86% decline from fiscal 2024.
- Fractyl Health, Inc. investment income, interest for fiscal 2024 was $4.15M, a 229.05% increase from fiscal 2023.
- Fractyl Health, Inc. investment income, interest for fiscal 2023 was $1.26M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $431.00K 10-Q · filed 2026-08-10 | $1.02M 10-Q · filed 2026-08-10 | $1.67M derived: sum of 3 quarters · filed 2026-08-10 | $1.83M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $593.00K 10-Q · filed 2026-05-12 | $1.24M derived: sum of 2 quarters · filed 2026-05-12 | $1.40M derived: sum of 3 quarters · filed 2026-05-12 | $1.63M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $811.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.04M derived: sum of 3 quarters · filed 2026-08-10 | $1.54M 10-K · filed 2026-03-24 |
| 2025-09-30 | $166.00K 10-Q · filed 2025-11-12 | $392.00K derived: sum of 2 quarters · filed 2026-08-10 | $895.00K 10-Q · filed 2025-11-12 | $1.62M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $226.00K 10-Q · filed 2026-08-10 | $729.00K 10-Q · filed 2026-08-10 | $1.46M derived: sum of 3 quarters · filed 2026-08-10 | $2.40M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $503.00K 10-Q · filed 2026-05-12 | $1.23M derived: sum of 2 quarters · filed 2026-05-12 | $2.18M derived: sum of 3 quarters · filed 2026-05-12 | $3.55M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $726.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.67M derived: sum of 2 quarters · filed 2026-03-24 | $3.05M derived: sum of 3 quarters · filed 2026-03-24 | $4.15M 10-K · filed 2026-03-24 |
| 2024-09-30 | $947.00K 10-Q · filed 2025-11-12 | $2.32M derived: sum of 2 quarters · filed 2025-11-12 | $3.42M 10-Q · filed 2025-11-12 | $3.88M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.38M 10-Q · filed 2025-08-12 | $2.47M 10-Q · filed 2025-08-12 | $2.94M derived: sum of 3 quarters · filed 2025-08-12 | $3.16M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-13 | $1.56M derived: sum of 2 quarters · filed 2025-05-13 | $1.79M derived: sum of 3 quarters · filed 2025-05-13 | $1.94M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $689.00K derived: sum of 2 quarters · filed 2025-03-03 | $843.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.26M 10-K · filed 2025-03-03 |
| 2023-09-30 | $226.00K 10-Q · filed 2024-11-12 | $380.00K derived: sum of 2 quarters · filed 2024-11-12 | $797.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $154.00K 10-Q · filed 2024-08-14 | $571.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $417.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |